-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Adhera Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2022.
- Adhera Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$3.54M, a 96.1% decline year-over-year.
- Adhera Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$4.49M, a 30.1% decline year-over-year.
- Adhera Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$2.11M, a 66.7% increase from 2021.
- Adhera Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$6.35M, a 68.6% decline from 2020.
- Adhera Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$3.77M, a 68.6% increase from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)